Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients-Reference-Cited by-同舟云学术

Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients

Published:2017-02 Issue: Volume:72 Page:124-136
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Frin Anne Claire,Evesque Ludovic,Gal Jocelyn,Benezery Karène,François Eric,Gugenheim Jean,Benizri Emmanuel,Château Yan,Marcié Serge,Doyen Jérome,Gérard Jean-Pierre

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Intracavitary irradiation of early rectal cancer for cure. A series of 186 cases;Papillon;Cancer,1975

2. Local excision and adjuvant radiotherapy for rectal adenocarcinoma T1-2 N0;Gérard;Gastroenterol Clin Biol,2000

3. Present status of radiation therapy in the conservative management of rectal cancer;Papillon;Radiother Oncol,1990

4. Long-term control of T2–T3 rectal adenocarcinoma with radiotherapy alone;Gérard;Int J Radiat Oncol Biol Phys,2002

5. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96-02 randomized trial;Gerard;J Clin Oncol,2004

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High Rates of Organ Preservation in Rectal Cancer with Papillon Contact X-ray Radiotherapy: Results from a Swiss Cohort;Cancers;2024-06-25

2. Executive Summary of the American Radium Society on Appropriate Use Criteria for Nonoperative Management of Rectal Adenocarcinoma: Systematic Review and Guidelines;International Journal of Radiation Oncology*Biology*Physics;2024-05

3. Low energy contact X‐ray brachytherapy for treatment of rectal cancer: a health technology appraisal by Health Technology Wales;Colorectal Disease;2024-03-11

4. The safety and efficacy of total mesorectal excision (TME) surgery following dose‐escalation: Surgical outcomes from the organ preservation in early rectal adenocarcinoma (OPERA) trial, a European multicentre phase 3 randomised trial (NCT02505750);Colorectal Disease;2023-10-13

5. High‐dose rate endorectal brachytherapy for rectal cancer: A state‐of‐the‐art review;Cancer Science;2023-09-13